The COMBAT HBV Feasibility Trial

NCT05705427 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

317

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B
Vertical Transmission of Infectious Disease

Interventions

DRUG: Tenofovir Disoproxil Fumarate 300 MG
BIOLOGICAL: Hepatitis B monovalent vaccine
DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]